Product Information
LAMOTRIGINE ODT 50 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.2753 per EA under NDC 49884048511. Its NADAC has been published 547 times since Mar 2, 2016.
FDA first approved this application on Oct 27, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Endo USA Inc.NDC
49884048511
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA204158FDA Approved
10/27/2015
TE Code
AB
On Market Since
12/16/2015
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ODT 50 MG TABLET has been published 547 times since Mar 2, 2016, and over the history we have for it it has declined 81.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2753 per EA |
|---|---|
| All-time high | $7.0944 (Jun 15, 2016) |
| All-time low | $1.2753 (Aug 19, 2026) |
| 52-week high | $1.7519 |
| 52-week low | $1.2753 |
| Median price | $4.8241 |
| Average price | $4.2218 |
| Largest weekly change | +55.3% (Mar 22, 2023) |
| Weeks tracked | 547 |
| Tracking since | Mar 2, 2016 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ODT 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ODT 50 MG TABLET, manufactured by Endo USA Inc., is $1.2753 per EA (NDC 49884048511), effective Aug 19, 2026.
How has the price of LAMOTRIGINE ODT 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ODT 50 MG TABLET has declined 81.2%. It has been tracked across 547 weekly CMS publications since Mar 2, 2016.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ODT 50 MG TABLET?
Since Mar 2, 2016, the NADAC for LAMOTRIGINE ODT 50 MG TABLET has ranged from a low of $1.2753 (Aug 19, 2026) to a high of $7.0944 (Jun 15, 2016), with a median of $4.8241 per EA.
Are there cheaper alternatives to LAMOTRIGINE ODT 50 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE ER 50 MG TABLET, is $0.5242 per EA — about 59% below LAMOTRIGINE ODT 50 MG TABLET.
Who manufactures LAMOTRIGINE ODT 50 MG TABLET?
LAMOTRIGINE ODT 50 MG TABLET (NDC 49884048511) is labeled by Endo USA Inc., and CMS classifies it as a generic product.